News and communications from MHRA

Over 3 million medicines and devices seized in UK as part of global crackdown
Source: News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) Published on 2021-06-08
The MHRA concludes positive safety profile for Pfizer/BioNTech vaccine in 12- to 15-year-olds
Source: News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) Published on 2021-06-04
PT jailed for sale of steroids and unlicensed medicines online
Source: News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) Published on 2021-05-28
One-dose Janssen COVID-19 vaccine approved by the MHRA
Source: News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) Published on 2021-05-28
Pfizer/BioNTech COVID-19 vaccine shelf-life extended from 5 to 31 days, says MHRA
Source: News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) Published on 2021-05-20
Regulator seeks views on reclassification of pain medication
Source: News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) Published on 2021-05-13
MHRA response to JCVI advice on COVID-19 Vaccine AstraZeneca for people aged under 40
Source: News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) Published on 2021-05-07
UK medicines regulator issues its first authorisation under Project Orbis
Source: News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) Published on 2021-05-07
MHRA announces appointment of Chief Safety Officer
Source: News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) Published on 2021-05-04
New commissioners appointed to the Commission on Human Medicines
Source: News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) Published on 2021-04-30
MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots
Source: News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) Published on 2021-04-07
Early Access continues during the coronavirus (COVID-19) pandemic
Source: News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) Published on 2021-04-06
MHRA pilots patient involvement in new applications
Source: News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) Published on 2021-03-23
UK regulator confirms that people should continue to receive the COVID-19 vaccine AstraZeneca
Source: News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) Published on 2021-03-18
Further MHRA response to the precautionary suspensions of COVID-19 Vaccine AstraZeneca
Source: News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) Published on 2021-03-16